Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:333-339
Published online before print January 3, 2002, doi: 10.1161/hh0302.104454
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
90/3/333    most recent
hh0302.104454v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terentis, A. C.
Right arrow Articles by Stocker, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terentis, A. C.
Right arrow Articles by Stocker, R.
Related Collections
Right arrow Lipid and lipoprotein metabolism
(Circulation Research. 2002;90:333.)
© 2002 American Heart Association, Inc.


Molecular Medicine

Vitamin E Oxidation in Human Atherosclerotic Lesions

Andrew C. Terentis, Shane R. Thomas, Jeanne A. Burr, Daniel C. Liebler, Roland Stocker

From the Biochemistry Group (A.C.T., S.R.T., R.S.), The Heart Research Institute, Camperdown, New South Wales, Australia; Department of Pharmacology and Toxicology (J.A.B., D.C.L.), College of Pharmacy, University of Arizona, Tucson, Ariz.

Correspondence to Professor Roland Stocker, The Heart Research Institute, 145 Missenden Rd, Camperdown, NSW, 2050, Australia. E-mail r.stocker{at}hri.org.au

Oxidation of low-density lipoproteins (LDL) is a key process in atherogenesis, and vitamin E ({alpha}-tocopherol, TOH) has received attention for its potential to attenuate the disease. Despite this, the type and extent of TOH oxidation and its relationship to lipid oxidation in the vessel wall where lesions develop remain unknown. Therefore, we measured oxidized lipids, TOH, and its oxidation products, {alpha}-tocopherylquinone (TQ), 2,3- and 5,6-epoxy-{alpha}-tocopherylquinones by gas chromatography–mass spectrometry analysis in human lesions representing different stages of atherosclerosis. We also oxidized LDL in vitro to establish "footprints" of TOH oxidation product for different oxidants. The in vitro studies demonstrated that tocopherylquinone epoxides are the major products when LDL is exposed to the one-electron (ie, radical) oxidants, peroxyl radicals, and copper ions, whereas TQ preferentially accumulates with the two-electron (nonradical) oxidants, hypochlorite, and peroxynitrite. In human lesions, the relative extent of TOH oxidation was maximal early in the disease where it exceeded lipid oxidation. Independent of the disease stage, TQ was always the major oxidation product with all products together representing <20% of the total TOH present, and the oxidation product profile mirroring that formed during LDL oxidation by activated monocytes in the presence of nitrite. In contrast, oxidized lipid increased with increasing disease severity. These results suggest that two-electron oxidants are primarily responsible for TOH oxidation in the artery wall, and that the extent of TOH oxidation is limited yet substantial lipid oxidation takes place. This study may have important implications regarding antioxidant supplements aimed at preventing LDL oxidation and hence atherogenesis.


Key Words: tocopherol • LDL oxidation • atherogenesis • hypochlorous acid




This article has been cited by other articles:


Home page
CirculationHome page
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al.
Managing Abnormal Blood Lipids: A Collaborative Approach
Circulation, November 15, 2005; 112(20): 3184 - 3209.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. S. Bruno and M. G. Traber
Cigarette Smoke Alters Human Vitamin E Requirements
J. Nutr., April 1, 2005; 135(4): 671 - 674.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kontush, M. J. Chapman, and R. Stocker
Vitamin E Is Not Deficient in Human Atherosclerotic Plaques
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): e139 - e140.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. M. Rezk, G. R. M. M. Haenen, W. J. F. van der Vijgh, and A. Bast
Lipoic Acid Protects Efficiently Only against a Specific Form of Peroxynitrite-induced Damage
J. Biol. Chem., March 12, 2004; 279(11): 9693 - 9697.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Stocker and R. A O'Halloran
Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall
Am. J. Clinical Nutrition, January 1, 2004; 79(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Griendling and G. A. FitzGerald
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Circulation, October 28, 2003; 108(17): 2034 - 2040.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
A. Dutta and S. K. Dutta
Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review
J. Am. Coll. Nutr., August 1, 2003; 22(4): 258 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Pankhurst, X. L. Wang, D. E. Wilcken, G. Baernthaler, U. Panzenbock, M. Raftery, and R. Stocker
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein
J. Lipid Res., February 1, 2003; 44(2): 349 - 355.
[Abstract] [Full Text] [PDF]